Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
30 Day Daily Return
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Month-End Total Returns as of 10/31/2024
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -5.65% | -9.72% | 20.07% | 6.26% | 45.93% | -12.62% | 4.32% | 0.00% | 15.45% | 04/07/2010 |
| BIB NAV | -5.52% | -9.53% | 20.43% | 6.34% | 46.24% | -12.56% | 4.33% | 0.03% | 15.46% | 04/07/2010 |
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -5.12% | 7.86% | 11.58% | 12.62% | 34.03% | -12.17% | 8.62% | 2.15% | 16.01% | 04/07/2010 |
| BIB NAV | -5.08% | 7.92% | 11.63% | 12.55% | 33.84% | -12.12% | 8.61% | 2.17% | 16.01% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.14%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
- Options Available Yes
Price
as of 11/29/2024- NAV $59.61
- NAV Change $-0.11
- Market Price $59.53
- Market Price Change $-0.12
- Trading Volume (M) 5,108
- 30-Day Median Bid Ask Spread 0.26%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.14%
- NAV Calculation Time 4:00 p.m. ET
- Options Available Yes
Price
as of 11/29/2024- NAV $59.61
- NAV Change $-0.11
- Market Price $59.53
- Market Price Change $-0.12
- Trading Volume (M) 5,108
- 30-Day Median Bid Ask Spread 0.26%
- View Premium / Discount
Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.
Exposures
Index as of 9/30/2024
Holdings
as of 11/29/2024
| Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
|---|---|---|---|---|---|---|
| 41.20% | -- | NASDAQ BIO INDEX SWAP BNP PARIBAS | 31,923,779 | -- | 6,873 | -- |
| 34.77% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 26,944,543 | -- | 5,801 | -- |
| 29.53% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 22,884,979 | -- | 4,927 | -- |
| 7.92% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 6,135,794 | -- | 1,321 | -- |
| 6.99% | GILD | GILEAD SCIENCES INC | -- | $5,418,799.98 | 58,531 | 2369174 |
| 6.24% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 4,835,247 | -- | 1,041 | -- |
| 5.70% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,417,214 | -- | 951 | -- |
| 5.63% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,365,780.38 | 9,326 | 2931034 |
| 5.06% | AMGN | AMGEN INC | -- | $3,917,466.63 | 13,849 | 2023607 |
| 4.09% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,172,405 | -- | 683 | -- |
| 3.78% | REGN | REGENERON PHARMACEUTICALS | -- | $2,928,858.88 | 3,904 | 2730190 |
| 2.85% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,207,522.52 | 32,646 | 2989044 |
| 2.35% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,821,091.72 | 7,196 | B00FWN1 |
| 1.69% | BIIB | BIOGEN INC | -- | $1,311,062.06 | 8,162 | 2455965 |
| 1.66% | ILMN | ILLUMINA INC | -- | $1,287,403.65 | 8,931 | 2613990 |
| 1.43% | ARGX | ARGENX SE - ADR | -- | $1,109,173.45 | 1,799 | BDVLM39 |
| 1.20% | MRNA | MODERNA INC | -- | $927,943.00 | 21,550 | BGSXTS3 |
| 1.19% | UTHR | UNITED THERAPEUTICS CORP | -- | $924,002.06 | 2,494 | 2430412 |
| 1.13% | VTRS | VIATRIS INC | -- | $875,851.90 | 66,910 | BMWS3X9 |
| 1.04% | INCY | INCYTE CORP | -- | $805,273.64 | 10,796 | 2471950 |
| 1.03% | SNY | SANOFI-ADR | -- | $794,751.10 | 16,390 | 2964557 |
| 0.97% | SMMT | SUMMIT THERAPEUTICS INC | -- | $749,734.44 | 40,614 | BMTVQS7 |
| 0.93% | INSM | INSMED INC | -- | $724,091.44 | 9,634 | 2614487 |
| 0.93% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $717,531.75 | 5,661 | 2623911 |
| 0.92% | SRPT | SAREPTA THERAPEUTICS INC | -- | $712,968.98 | 5,347 | B8DPDT7 |
| 0.91% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $704,804.22 | 10,674 | 2437071 |
| 0.86% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $669,672.54 | 25,119 | BMVP7Y0 |
| 0.84% | BNTX | BIONTECH SE-ADR | -- | $650,671.44 | 5,496 | BK6H543 |
| 0.76% | MEDP | MEDPACE HOLDINGS INC | -- | $592,696.20 | 1,740 | BDCBC61 |
| 0.76% | PCVX | VAXCYTE INC | -- | $590,379.72 | 6,258 | BKPVGH6 |
| 0.75% | EXEL | EXELIXIS INC | -- | $583,141.24 | 15,994 | 2576941 |
| 0.70% | RVMD | REVOLUTION MEDICINES INC | -- | $541,765.25 | 9,365 | BL71K91 |
| 0.69% | BGNE | BEIGENE LTD-ADR | -- | $532,340.00 | 2,476 | BYYWPW6 |
| 0.68% | ROIV | ROIVANT SCIENCES LTD | -- | $526,893.05 | 41,455 | BMW4NZ9 |
| 0.65% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $507,219.30 | 5,922 | BHCB0P4 |
| 0.57% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $441,987.84 | 3,248 | BV9G6B8 |
| 0.54% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $420,944.58 | 3,462 | B4Q5ZN4 |
| 0.51% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $398,094.47 | 1,213 | BD59BS7 |
| 0.44% | BPMC | BLUEPRINT MEDICINES CORP | -- | $342,438.14 | 3,553 | BWY52P3 |
| 0.44% | HALO | HALOZYME THERAPEUTICS INC | -- | $342,268.20 | 7,101 | 2975098 |
| 0.44% | CYTK | CYTOKINETICS INC | -- | $342,016.70 | 6,595 | BBBSBJ5 |
| 0.41% | NUVL | NUVALENT INC-A | -- | $321,557.68 | 3,326 | BMVBZD3 |
| 0.41% | KRYS | KRYSTAL BIOTECH INC | -- | $317,648.78 | 1,609 | BD6JX35 |
| 0.38% | IONS | IONIS PHARMACEUTICALS INC | -- | $292,878.81 | 8,197 | BDJ0LS6 |
| 0.37% | BBIO | BRIDGEBIO PHARMA INC | -- | $285,555.69 | 10,541 | BK1KWG8 |
| 0.36% | RNA | AVIDITY BIOSCIENCES INC | -- | $282,491.95 | 6,565 | BMWHPY1 |
| 0.35% | ALKS | ALKERMES PLC | -- | $267,941.66 | 9,233 | B3P6D26 |
| 0.34% | ACLX | ARCELLX INC | -- | $265,531.05 | 3,015 | BPCJ1Q2 |
| 0.34% | AXSM | AXSOME THERAPEUTICS INC | -- | $264,310.02 | 2,691 | BYZR4X4 |
| 0.34% | ADMA | ADMA BIOLOGICS INC | -- | $262,777.37 | 13,067 | B9NSBM2 |
| 0.33% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $256,599.20 | 4,486 | BDD19F8 |
| 0.32% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $246,104.21 | 5,167 | BJ62Z18 |
| 0.32% | GH | GUARDANT HEALTH INC | -- | $245,424.12 | 6,892 | BFXC911 |
| 0.32% | CRSP | CRISPR THERAPEUTICS AG | -- | $244,234.41 | 4,773 | BDHF4K6 |
| 0.30% | APLS | APELLIS PHARMACEUTICALS INC | -- | $231,640.11 | 6,827 | BYTQ6X1 |
| 0.30% | IMVT | IMMUNOVANT INC | -- | $231,437.40 | 8,207 | BJRFSB7 |
| 0.27% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $212,549.04 | 3,426 | BF2YWG4 |
| 0.26% | DNLI | DENALI THERAPEUTICS INC | -- | $200,675.00 | 8,027 | BD2B4V0 |
| 0.25% | IBRX | IMMUNITYBIO INC | -- | $196,806.96 | 39,049 | BNSP0B8 |
| 0.25% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $192,596.46 | 4,578 | BMX9K07 |
| 0.24% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $189,454.10 | 3,190 | BCBVTX1 |
| 0.24% | PTCT | PTC THERAPEUTICS INC | -- | $189,210.56 | 4,312 | B17VCN9 |
| 0.24% | VCYT | VERACYTE INC | -- | $184,899.75 | 4,305 | BFTWZY0 |
| 0.23% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $181,481.16 | 6,972 | BYQBFJ8 |
| 0.23% | XENE | XENON PHARMACEUTICALS INC | -- | $181,134.87 | 4,249 | BRJ3GY4 |
| 0.23% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $178,991.40 | 4,486 | BFZQ0L8 |
| 0.22% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $173,481.00 | 5,257 | BKY5JZ8 |
| 0.22% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $172,764.20 | 4,165 | BGMGM89 |
| 0.22% | DYN | DYNE THERAPEUTICS INC | -- | $172,395.52 | 5,632 | BN15WD1 |
| 0.22% | MRUS | MERUS NV | -- | $171,513.00 | 3,825 | BZBY005 |
| 0.22% | KYMR | KYMERA THERAPEUTICS INC | -- | $169,643.85 | 3,621 | BMPRZV5 |
| 0.21% | FOLD | AMICUS THERAPEUTICS INC | -- | $165,887.56 | 16,622 | B19FQ48 |
| 0.21% | TWST | TWIST BIOSCIENCE CORP | -- | $161,654.66 | 3,287 | BGKG6G7 |
| 0.21% | VRNA | VERONA PHARMA PLC - ADR | -- | $160,342.98 | 4,046 | BYWPZK5 |
| 0.21% | VCEL | VERICEL CORP | -- | $159,478.02 | 2,743 | BSBMN89 |
| 0.20% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $158,579.80 | 17,015 | BF0DMK7 |
| 0.20% | VERA | VERA THERAPEUTICS INC | -- | $152,931.50 | 3,074 | BL55460 |
| 0.20% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $151,759.68 | 9,299 | 2713317 |
| 0.19% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $144,627.60 | 3,302 | BDCBCD8 |
| 0.18% | GERN | GERON CORP | -- | $139,223.04 | 33,792 | 2370381 |
| 0.17% | JANX | JANUX THERAPEUTICS INC | -- | $132,284.46 | 2,926 | BMFX8Y7 |
| 0.17% | IDYA | IDEAYA BIOSCIENCES INC | -- | $129,440.16 | 4,731 | BK0VHF6 |
| 0.16% | BEAM | BEAM THERAPEUTICS INC | -- | $126,504.14 | 4,622 | BK6L288 |
| 0.16% | AKRO | AKERO THERAPEUTICS INC | -- | $124,997.40 | 3,894 | BK7Y2V9 |
| 0.16% | LGND | LIGAND PHARMACEUTICALS | -- | $124,385.28 | 1,024 | 2501578 |
| 0.16% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $124,262.32 | 17,576 | BM9FJ13 |
| 0.16% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $123,499.84 | 2,672 | BJDX8Y8 |
| 0.16% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $123,413.89 | 2,731 | BNFWZS4 |
| 0.16% | NVCR | NOVOCURE LTD | -- | $121,602.72 | 6,068 | BYSS4X4 |
| 0.16% | KROS | KEROS THERAPEUTICS INC | -- | $121,484.96 | 2,104 | BM7V485 |
| 0.15% | APGE | APOGEE THERAPEUTICS INC | -- | $113,958.60 | 2,524 | BM9HHL5 |
| 0.15% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $113,001.30 | 3,090 | B72ZBG4 |
| 0.14% | TARS | TARSUS PHARMACEUTICALS INC | -- | $111,823.40 | 2,132 | BMH5RL1 |
| 0.14% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $110,721.00 | 3,340 | BQS9486 |
| 0.14% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $110,493.29 | 3,187 | BKSGZN7 |
| 0.14% | IRON | DISC MEDICINE INC | -- | $105,898.05 | 1,669 | BMGJZJ8 |
| 0.14% | FTRE | FORTREA HOLDINGS INC | -- | $105,713.10 | 5,022 | BRXYZ57 |
| 0.14% | WVE | WAVE LIFE SCIENCES LTD | -- | $105,518.80 | 6,988 | BYZG9R0 |
| 0.13% | MNKD | MANNKIND CORP | -- | $104,527.26 | 15,417 | BF081J4 |
| 0.13% | ARVN | ARVINAS INC | -- | $102,791.84 | 3,847 | BDZ30Q0 |
| 0.12% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $94,430.98 | 7,343 | BRJZSK0 |
| 0.11% | NTLA | INTELLIA THERAPEUTICS INC | -- | $88,971.52 | 5,696 | BYZM6C2 |
| 0.11% | XNCR | XENCOR INC | -- | $88,755.20 | 3,467 | BGCYWN8 |
| 0.11% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $86,970.00 | 11,596 | 2100362 |
| 0.11% | OCUL | OCULAR THERAPEUTIX INC | -- | $86,448.49 | 8,741 | BNZB1X8 |
| 0.11% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $85,451.12 | 6,553 | BKX9VD3 |
| 0.11% | HROW | HARROW INC | -- | $83,317.08 | 1,988 | BHNDW86 |
| 0.11% | MYGN | MYRIAD GENETICS INC | -- | $82,863.11 | 5,093 | 2614153 |
| 0.10% | TVTX | TRAVERE THERAPEUTICS INC | -- | $80,600.85 | 4,285 | BLFGJD5 |
| 0.10% | ZLAB | ZAI LAB LTD-ADR | -- | $80,376.10 | 2,786 | BD9GVY0 |
| 0.10% | NRIX | NURIX THERAPEUTICS INC | -- | $79,817.10 | 3,610 | BMVLGP2 |
| 0.10% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $79,737.68 | 4,769 | BN7Q7R7 |
| 0.10% | SPRY | ARS PHARMACEUTICALS INC | -- | $78,876.36 | 5,436 | BMCR7V2 |
| 0.10% | NVAX | NOVAVAX INC | -- | $78,227.12 | 8,971 | BJDQXG4 |
| 0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $77,966.21 | 5,597 | BLB0YH0 |
| 0.10% | ARDX | ARDELYX INC | -- | $74,849.67 | 13,201 | BN89V40 |
| 0.09% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $73,417.78 | 5,102 | BDFKQ07 |
| 0.09% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $71,021.76 | 8,016 | BFWLC09 |
| 0.09% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $70,977.33 | 3,963 | BLB0YQ9 |
| 0.09% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $70,914.84 | 2,166 | BLCD809 |
| 0.09% | ANIP | ANI PHARMACEUTICALS INC | -- | $67,531.40 | 1,180 | BCDWBX6 |
| 0.09% | INVA | INNOVIVA INC | -- | $66,616.92 | 3,508 | BDDXF67 |
| 0.08% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $64,558.24 | 2,648 | BMFD115 |
| 0.08% | VIR | VIR BIOTECHNOLOGY INC | -- | $60,973.60 | 7,660 | BK4PZ38 |
| 0.08% | AVDL | AVADEL PHARMACEUTICALS | -- | $59,679.76 | 5,396 | BDGMC59 |
| 0.08% | COGT | COGENT BIOSCIENCES INC | -- | $58,353.36 | 6,136 | BLR6XK8 |
| 0.07% | ZYME | ZYMEWORKS INC | -- | $56,134.56 | 3,984 | BPCQZY9 |
| 0.07% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $55,083.00 | 1,806 | BX7RSN3 |
| 0.07% | REPL | REPLIMUNE GROUP INC | -- | $53,870.08 | 3,826 | BDDVW37 |
| 0.07% | ETNB | 89BIO INC | -- | $53,373.63 | 5,937 | BK1K484 |
| 0.07% | GMAB | GENMAB A/S -SP ADR | -- | $50,568.00 | 2,352 | BBC9WC7 |
| 0.06% | KNSA | KINIKSA PHARMACEUTICALS INTE | -- | $50,276.16 | 2,277 | BRXB0C0 |
| 0.06% | ABCL | ABCELLERA BIOLOGICS INC | -- | $49,722.19 | 16,519 | BL53SR3 |
| 0.06% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $49,105.98 | 8,267 | BJ5FZ74 |
| 0.06% | PRTA | PROTHENA CORP PLC | -- | $48,889.36 | 3,016 | B91XRN2 |
| 0.06% | EOLS | EVOLUS INC | -- | $48,421.53 | 3,537 | BDRJH21 |
| 0.06% | GRFS | GRIFOLS SA-ADR | -- | $47,797.62 | 6,838 | B8K7T65 |
| 0.06% | KURA | KURA ONCOLOGY INC | -- | $47,405.76 | 4,294 | BYZD465 |
| 0.06% | CSTL | CASTLE BIOSCIENCES INC | -- | $47,115.68 | 1,556 | BKLCWZ3 |
| 0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $47,044.20 | 3,409 | BMDWW66 |
| 0.06% | ERAS | ERASCA INC | -- | $45,282.38 | 15,833 | BNLYBF3 |
| 0.06% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $45,008.46 | 7,938 | BMCWKZ2 |
| 0.06% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $44,972.84 | 4,754 | BYTYP72 |
| 0.06% | CGEM | CULLINAN THERAPEUTICS INC | -- | $43,725.95 | 3,251 | BM90J52 |
| 0.06% | PCRX | PACIRA BIOSCIENCES INC | -- | $43,712.35 | 2,585 | B3X26D8 |
| 0.05% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $42,452.40 | 2,081 | BKDQKM6 |
| 0.05% | ANAB | ANAPTYSBIO INC | -- | $42,232.32 | 1,692 | BDRW1L7 |
| 0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $39,144.60 | 3,954 | BKVDFF7 |
| 0.05% | TRML | TOURMALINE BIO INC | -- | $37,419.48 | 1,437 | BQ80NC6 |
| 0.05% | TSHA | TAYSHA GENE THERAPIES INC | -- | $37,230.84 | 11,491 | BNC1BX1 |
| 0.05% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $37,157.44 | 11,192 | BFMLGR4 |
| 0.05% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $36,624.10 | 10,585 | BZ0QMB7 |
| 0.05% | CVAC | CUREVAC NV | -- | $36,078.77 | 12,571 | BN4RD42 |
| 0.05% | MLYS | MINERALYS THERAPEUTICS INC | -- | $35,589.99 | 2,787 | BP9N0G0 |
| 0.05% | RLAY | RELAY THERAPEUTICS INC | -- | $35,282.90 | 7,507 | BN2R582 |
| 0.04% | SANA | SANA BIOTECHNOLOGY INC | -- | $34,674.94 | 12,473 | BMFJJ97 |
| 0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $33,972.10 | 3,830 | BJLKVS6 |
| 0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $32,485.20 | 3,210 | BMZ4LN0 |
| 0.04% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $31,528.64 | 8,957 | B3MZ6K5 |
| 0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $31,371.40 | 1,135 | B292NQ7 |
| 0.04% | SVRA | SAVARA INC | -- | $31,009.44 | 9,229 | BYXGN81 |
| 0.04% | GRAL | GRAIL INC | -- | $30,467.50 | 1,741 | BSLSSX7 |
| 0.04% | HUMA | HUMACYTE INC | -- | $30,243.32 | 6,691 | BMYTJP4 |
| 0.04% | URGN | UROGEN PHARMA LTD | -- | $29,972.00 | 2,360 | BZ7PJQ1 |
| 0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $29,764.24 | 2,497 | BG31GH0 |
| 0.04% | HCM | HUTCHMED CHINA-ADR | -- | $29,509.95 | 1,741 | BYXV9H7 |
| 0.04% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $29,381.80 | 4,340 | BFYQFJ2 |
| 0.04% | THRD | THIRD HARMONIC BIO INC | -- | $29,373.52 | 2,302 | BNNPQY8 |
| 0.04% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $29,171.43 | 15,273 | B4N8MH9 |
| 0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $29,134.56 | 4,002 | 2107437 |
| 0.04% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $29,075.52 | 11,724 | BFZNYB7 |
| 0.04% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $27,785.10 | 1,515 | BKC9SX3 |
| 0.04% | RGNX | REGENXBIO INC | -- | $27,478.40 | 2,770 | BZ0G875 |
| 0.04% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $27,391.28 | 8,351 | BLR7H87 |
| 0.04% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $27,337.65 | 3,089 | BMGS7L1 |
| 0.03% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $26,618.43 | 1,139 | BL95N25 |
| 0.03% | VERV | VERVE THERAPEUTICS INC | -- | $26,608.23 | 4,743 | BNKGXX2 |
| 0.03% | OABI | OMNIAB INC | -- | $25,884.20 | 6,620 | BN13S71 |
| 0.03% | SLRN | ACELYRIN INC | -- | $25,457.25 | 5,595 | BQPF874 |
| 0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $25,382.00 | 2,744 | BMNDK09 |
| 0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $24,610.56 | 3,944 | BMDJ0C9 |
| 0.03% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $24,294.90 | 2,415 | BD06CS0 |
| 0.03% | TNGX | TANGO THERAPEUTICS INC | -- | $23,667.58 | 6,007 | BP2P6L0 |
| 0.03% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $22,845.76 | 2,914 | BKLXFX5 |
| 0.03% | PRME | PRIME MEDICINE INC | -- | $22,138.41 | 6,729 | BPBJFM7 |
| 0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $21,215.97 | 5,877 | BJFSR99 |
| 0.03% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $21,146.18 | 3,817 | BPCK358 |
| 0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $20,964.16 | 3,056 | BY7RB53 |
| 0.03% | MXCT | MAXCYTE INC | -- | $20,920.15 | 5,893 | BKMQF66 |
| 0.02% | ACIU | AC IMMUNE SA | -- | $18,832.60 | 5,539 | BZC0D70 |
| 0.02% | SAGE | SAGE THERAPEUTICS INC | -- | $18,718.34 | 3,422 | BP4GNK9 |
| 0.02% | ITOS | ITEOS THERAPEUTICS INC | -- | $17,510.40 | 2,048 | BMWXFT4 |
| 0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $16,830.20 | 3,268 | B12W3P6 |
| 0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $16,746.24 | 9,408 | BN6M8F1 |
| 0.02% | QURE | UNIQURE NV | -- | $16,310.04 | 2,732 | BJFSR88 |
| 0.02% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $16,286.18 | 20,264 | BWFZX59 |
| 0.02% | ACRS | ACLARIS THERAPEUTICS INC | -- | $16,280.00 | 4,000 | BYV2W40 |
| 0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $16,176.60 | 4,730 | BLN9Z50 |
| 0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $15,749.44 | 7,031 | BNG1NK8 |
| 0.02% | PGEN | PRECIGEN INC | -- | $15,034.77 | 16,130 | BKM5C84 |
| 0.02% | BMEA | BIOMEA FUSION INC | -- | $14,668.24 | 2,026 | BNKF6N0 |
| 0.02% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $14,396.68 | 3,988 | BMQ5T49 |
| 0.02% | ALEC | ALECTOR INC | -- | $14,120.68 | 5,452 | BJ4LDC4 |
| 0.02% | LYEL | LYELL IMMUNOPHARMA INC | -- | $13,565.02 | 14,353 | BN6MB18 |
| 0.02% | FULC | FULCRUM THERAPEUTICS INC | -- | $13,467.30 | 3,498 | BJDX8Z9 |
| 0.02% | MGNX | MACROGENICS INC | -- | $12,622.44 | 3,516 | BFDV8K0 |
| 0.01% | AMRN | AMARIN CORP PLC -ADR | -- | $11,366.80 | 22,433 | 2301938 |
| 0.01% | CRBU | CARIBOU BIOSCIENCES INC | -- | $11,094.54 | 5,066 | BNYJR68 |
| 0.01% | VTYX | VENTYX BIOSCIENCES INC | -- | $10,618.16 | 3,962 | BMG99Y1 |
| 0.01% | CABA | CABALETTA BIO INC | -- | $10,466.80 | 2,740 | BK5MWR1 |
| 0.01% | EDIT | EDITAS MEDICINE INC | -- | $10,360.00 | 4,625 | BZ8FPH3 |
| 0.01% | CHRS | COHERUS BIOSCIENCES INC | -- | $7,877.54 | 6,457 | BRK0149 |
| 0.01% | OVID | OVID THERAPEUTICS INC | -- | $4,536.06 | 3,979 | BYPFK63 |
| 0.01% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $4,367.48 | 2,951 | BLN7XQ1 |
| 0.01% | BLUE | BLUEBIRD BIO INC | -- | $4,322.16 | 10,672 | BBFL7S1 |
| -- | ME | 23ANDME HOLDING CO -CLASS A | -- | $3,368.95 | 949 | BRK1ZT5 |
| -- | OKUR | ONKURE THERAPEUTICS INC-A | -- | $2,914.38 | 189 | BT7KGT6 |
| -- | RAPT | RAPT THERAPEUTICS INC | -- | $2,464.56 | 1,956 | BK5T6R0 |
| -- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
| -- | MRNS | MARINUS PHARMACEUTICALS INC | -- | $1,002.36 | 3,088 | BM8MVZ3 |
| -- | -- | TREASURY BILL | -- | $9,996,300.00 | 10,000,000 | BNNRNL0 |
| -- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $12,610,195.38 | 12,610,195 | -- |
Index
as of 9/30/2024
- Total Number of Companies214
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$7.59 billion
About the Index
The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.
Distributions
For
2024
- 2024
- 2023
- 2022
| Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
|---|
Portfolio Hedging Series
Part I: The Significance of Portfolio Hedging
Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More